Wednesday, December 30, 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3hzEsrl
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A heavy monsoon season is great news for these Indian stocks

The Nifty FMCG Index has risen 1.5% so far in May, beating the benchmark NSE Nifty 50 Index by more than two percentage points. It underperf...